Precision Medicine in Hormone Receptor-Positive Breast Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference122 articles.
1. Breast Cancer Facts & Figures 2017–20182017
2. Cancer Facts and Figures 20172017
3. Tamoxifen from failed contraceptive pill to best-selling breast cancer medicine: a case-study in pharmaceutical innovation;Quirke;Front Pharmacol,2017
4. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women;N Engl J Med,1988
5. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet,2011
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti–MUC1 nanobody can synergize the Tamoxifen and Herceptin effects on breast cancer cells by inducing ER, PR and HER2 overexpression;International Immunopharmacology;2023-11
2. Selecting Triple Negative Breast Cancer Patients for Immunotherapy;Surgical Oncology Clinics of North America;2023-10
3. The management of locally advanced, ulcerated breast cancer in a menopausal woman: a case report;Annals of Medicine & Surgery;2023-08-14
4. Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer;International Journal of Biological Macromolecules;2023-05
5. Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors;2023-04-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3